Skip to main content
Top

2017 | OriginalPaper | Hoofdstuk

13 Contrastmiddelen

Auteur : Anton Brouwers

Gepubliceerd in: Radiologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

De ontdekking van de röntgenstralen door Wilhelm Conrad Röntgen op 8 november 1895 bracht een nieuwe ontwikkeling in de medische wereld: de beeldvormende techniek. De technische ontwikkeling om die beeldvorming te verbeteren is nog steeds in volle gang. Echter, tot op de dag van vandaag is er sprake van beperkingen van deze techniek, bijvoorbeeld bij de beeldvorming van organen, spieren en bloedvaten.
Literatuur
go back to reference Brouwers ACAA. Handout contrastmiddelen NVMBR. Bayer Schering Pharma; 2009. Brouwers ACAA. Handout contrastmiddelen NVMBR. Bayer Schering Pharma; 2009.
go back to reference College voor zorgverzekeringen. Farmacotherapeutisch kompas. Diemen: CVZ; 2010. College voor zorgverzekeringen. Farmacotherapeutisch kompas. Diemen: CVZ; 2010.
go back to reference Hexabrix en Telebrix, summary of product characteristics (SMPC). Guerbet. Hexabrix en Telebrix, summary of product characteristics (SMPC). Guerbet.
go back to reference Iomeron, summary of product characteristics (SMPC). Bracco. Iomeron, summary of product characteristics (SMPC). Bracco.
go back to reference Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology June 1990 175:621-628.CrossRef Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology June 1990 175:621-628.CrossRef
go back to reference Loembé B. Handout contrastnefropathie (Contrast Induced Nephropathy, CIN). Bayer Healthcare. Loembé B. Handout contrastnefropathie (Contrast Induced Nephropathy, CIN). Bayer Healthcare.
go back to reference Schering AG. 75 years of diagnostic research, shaping the future. Schering AG. 75 years of diagnostic research, shaping the future.
go back to reference Schering AG. More than 75 years of diagnostic research, evolutionary steps. Schering AG. More than 75 years of diagnostic research, evolutionary steps.
go back to reference Schild HH. Radiological procedures and techniques, all you will ever need to know. Germany 1993. Schild HH. Radiological procedures and techniques, all you will ever need to know. Germany 1993.
go back to reference Siers E. Contrastmiddelen. Utrecht: Wetenschapswinkel Biologie; 1999. Siers E. Contrastmiddelen. Utrecht: Wetenschapswinkel Biologie; 1999.
go back to reference Thomsen HS, Webb JAW. Contrast media, safety issues and ESUR guidelines. 2nd ed. Berlin: Springer-Verlag; 2009. Thomsen HS, Webb JAW. Contrast media, safety issues and ESUR guidelines. 2nd ed. Berlin: Springer-Verlag; 2009.
go back to reference Ultravist Monograaf, Bayer Schering Pharma. Ultravist Monograaf, Bayer Schering Pharma.
go back to reference Ultravist, summary of product characteristics (SMPC). Bayer Schering Pharma. Ultravist, summary of product characteristics (SMPC). Bayer Schering Pharma.
go back to reference Urich K. Successes and failures in the development of contrast media, from Wilhelm C. Röntgen to the present. Berlin: Blackwell Wissenschaft-Verlag; 1995. Urich K. Successes and failures in the development of contrast media, from Wilhelm C. Röntgen to the present. Berlin: Blackwell Wissenschaft-Verlag; 1995.
go back to reference Visipaque en Omnipaque, summary of product characteristics (SMPC). GE Healthcare. Visipaque en Omnipaque, summary of product characteristics (SMPC). GE Healthcare.
Metagegevens
Titel
13 Contrastmiddelen
Auteur
Anton Brouwers
Copyright
2017
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-1455-3_19